179
Views
1
CrossRef citations to date
0
Altmetric
Commentaries

Exhausted and outnumbered: CD4+ T cells in the myeloma battlefield

&
Pages 1777-1779 | Received 25 May 2020, Accepted 25 May 2020, Published online: 16 Jun 2020
 

Disclosure statement

Dr. Manasanch reports grants from Sanofi, Quest Diagnostics, Novartis, JW Pharma, Merck, other from Takeda, Celgene, Sanofi, Janssen, GSK, Adaptive Biotechnologies, Secura Bio, outside the submitted work.

Additional information

Funding

This study was supported by National Institutes of Health [P30 CA016672].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.